Nigerian manufacturers capable of producing vaccines, Tinubu tells GAVI
President Bola Tinubu has called on GAVI, the Vaccine Alliance, to collaborate with potential Nigerian vaccine manufacturers to ensure equitable access to life-saving vaccines for children and adults. Speaking at a meeting with a delegation of GAVI led by its Chief Executive Officer, Dr. Sania Nishtar, at the State House, on Thursday, President Tinubu said […]
President Bola Tinubu
President Bola Tinubu has called on GAVI, the Vaccine Alliance, to collaborate with potential Nigerian vaccine manufacturers to ensure equitable access to life-saving vaccines for children and adults.
Speaking at a meeting with a delegation of GAVI led by its Chief Executive Officer, Dr. Sania Nishtar, at the State House, on Thursday, President Tinubu said partnership on local vaccine production has become necessary owing to the challenges faced by developing countries, especially during the COVID-19 pandemic and other infectious disease outbreaks.
‘’We have capable and talented people who can make the necessary contributions to the production of vaccines in Nigeria and the rest of Africa,’’ the President told the visiting CEO, who assumed office on March 18, 2024, and has embarked on visits to some African countries.
The president assured the GAVI CEO of Nigeria’s commitment to fulfilling its outstanding counterpart contributions for routine vaccines for the year 2023.
Nigeria on a challenging path, says Tinubu
He directed the Coordinating Minister of Health and Social Welfare, Professor Muhammad Ali Pate, to work with the Coordinating Minister of the Economy and Minister of Finance to ensure the release of necessary funds for vaccine procurement.
In her remarks, the GAVI CEO congratulated the Nigerian government on its innovative health-sector initiatives, including increasing budgetary allocations to health to 4.6 per cent and commitment to providing HPV vaccines for adolescent girls, among others.
She expressed readiness to collaborate with the Federal Ministry of Health and Social Welfare to leverage policy instruments and technical expertise to advance health outcomes.